Frequently Asked Questions
Do not alter the dosage amount or schedule of any drug you are taking without first consulting your doctor or pharmacists.

How has DNA Prescription Drug Reaction Testing been used up to this point?
Pharmaceutical companies regularly use these tests in clinical trials, to exclude people from the trials. Medical centers around the country are also beginning to use these tests on their own patients to avoid adverse drug reactions (ADRs) and achieve more accurate prescribing.

Why is this testing just now becoming available?
There are many reasons. Key elements of this test have recently been developed. ADRs don't have an organized constituency like most diseases do, no American Cancer Society or March of Dimes. Many doctors do not realize the extent of the problem and the large pharmaceutical companies and insurers may have a difficult time becoming motivated to act because of the added initial costs. Genelex has made this test available to the public so people can benefit now from the recent advances in pharmacogenetics. We also wish to recognize that more people want to take greater responsibility for their own healthcare. We support that decision.

What is pharmacogenetics?
Pharmacogenetics is the study of how individual people respond to medicines based on their genetic makeup. When you take a drug or are exposed to an environmental toxin, enzymes in your liver, intestines and other tissues go to work to breakdown that drug so that it can be excreted. Your genes provide the instructions for making these enzymes, several of which may be involved in the breakdown and excretion of any particular drug. Your specific genetic makeup determines how these enzymes interact and whether they work faster or slower than average.

How are drugs processed by the body?
Drugs act on target sites in body tissues to cause a therapeutic effect. They are removed from the body by being converted into an inactive form. The P-450 family of drug metabolizing enzymes inactivates most prescription drugs. The most important and most thoroughly studied of these enzymes are CYP2D6 and CYP2C9. More than half of the population has at least one defect in these enzymes that can greatly increase the risk of an adverse drug reaction.

What are adverse drug reactions?
Adverse drug reactions (ADRs) depend on the type of drug or combination of drugs being taken. They have many causes and are often not well understood. Many ADRs occur because individual differences in drug metabolizing enzymes (DMEs) and other parts of the processing systems have not been taken into account when the drug was approved or prescribed. Three-fourths of all ADRs are dose-dependent, with many occurring at standard manufacturer-recommended doses. A 1998 medical report found adverse drug reactions to be the fourth leading cause of death in the U.S., at more than 100,000 annually. .

What are the most useful enzymes to test genetically?
CYP2D6 (cytochrome P450 2D6) is the best studied of the DMEs (drug metabolizing enzymes) and acts on one quarter of all prescription drugs. Approximately ten percent of the population have a slow acting form of this enzyme and five percent a super-fast acting form. Drugs that CYP2D6 are thought to inactivate include Prozac, Zoloft, Paxil, Effexor,Hydrocodone, Amitriptyline, Claritin, Cyclobenzaprine, Haldol, Metoprolol, Rythmol, Tagamet, Tamoxifen, and the over-the-counter diphenylhydramine drugs, Allegra, Dytuss and Tusstat.

CYP2C9 (cytochrome P450 2C9) is the primary route of metabolism for Coumadin (Warfarin), Amaryl, Isoniazid, Sulfa and Ibuprofen. Clinical studies suggest that the use of genetic testing may be especially helpful with warfarin administration. Other drugs that are thought to be metaboloized by 2C9 include, Amitriptyline, Dilantin, Hyzaar, THC (tetrahydrocannabinol), Naproxen and Viagra.

CYP2C19 (cytochrome P450 2C19) is associated with the metabolism of Carisoprodol, Diazepam, Dilantin, Premarin and Prevacid.

NAT2 (N-acetyltransferase 2) is a second step drug metabolizing enzyme that acts on Isoniazid, and Procainamide and Azulfidine. The frequency of the NAT2 "slow acetylator" in various worldwide populations ranges from 10% to more than 90%.

For additional information on these and other prescription drugs visit http://www.rxlist.com/top200.htm.


How will my doctor or pharmacist use my personal DNA Prescription Drug Reaction Profile?
Prescription drugs on the market today have been tested and approved in a "one size fits all" manner despite the long-established knowledge that drug inactivation rates vary greatly from person to person. Now for the first time your health care providers can learn about your individual drug reaction profile and that can help them take better care of you.


Check Common Drugs Processed by Enzymes We Test

Order DNA Prescription Drug Reaction Profile

      

Founded in 1987, Genelex Corporation is accredited by the American Association of Blood Banks (AABB)Parentage Testing Committee in DNA parentage testing since 1992 and is Washington State Medical Test Site No. MTS-3919 CLIA No. 50D0980559. Genelex was accredited by the American Society of Crime Laboratory Directors Laboratory Accreditation Board (ASCLD LAB) in forensic DNA testing from 1998-2003 and has contributed to the validation of National Institute of Standards and Technology (NIST) Standard Reference Materials.

 
©2002, Genelex Corporation. All Rights Reserved.